Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 5, 2026Journal of Neonatology

Incidence of Metabolic Bone Disease in Preterms <32 Weeks Gestation in a Tertiary Care Center: A Prospective Observational Study

View Full Paper
Ask AI
Bookmark
Share

Authors

APAnupama S PillaiARAswathy RahulSKSobha Kumar

Discussion

Loading...

Member takes

Overview

Prospective observational study estimates metabolic bone disease incidence in preterm infants, suggesting the need for timely intervention.

Key Points

  • The goal is to estimate the incidence of metabolic bone disease in preterm infants under 32 weeks gestation and examine associated clinical factors.
  • Conducted a prospective observational study in a neonatal intensive care unit.
  • Included all preterm babies born under 32 weeks gestation with parental consent.
  • Evaluated incidence of metabolic bone disease and clinical profiles.
  • The incidence of metabolic bone disease was found to be 40%.
  • 88.8% of cases were detected by 2 weeks of postnatal age, with late presentation in lower gestational ages.
  • 22.38% of babies did not respond to treatment in the initial 2 weeks.

Cite This Study

Pillai et al. (2026) studied this question.

synapsesocial.com/papers/6984358ff1d9ada3c1fb4748https://doi.org/10.1177/09732179261418412
View Full Paper
Ask AI
Bookmark
Share